Abstract
There are several diseases associated with group A beta hemolytic streptococcal infection; the two most common are acute rheumatic fever (ARF) and poststreptococcal reactive arthritis (PsRA). Epidemiological and clinical data for both diseases are described, as well as current recommendations for treatment and prevention. There is an ongoing debate as to whether these two are different diseases or are parts of the spectrum of the same disease. There are some reports of carditis developing after PsRA, suggesting that PsRA may be part of the spectrum of ARF. However, since there are substantial clinical, immunological, and genetic differences between PsRA and ARF, we believe PsRA to be a distinct entity.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
• Seckeler MD, Hoke TR. The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease. Clin Epidemiol. 2011;3(1):67–84. This paper brings to attention the fact that acute rheumatic fever is still a considerable problem in pediatrics, more so in developing countries, but not only in them.
Tibazarwa KB, Volmink JA, Mayosi BM. The incidence of acute rheumatic fever in the world: a systematic review of population based studies. Heart. 2008;94:1534–40.
Wolfe R. Incidence of acute rheumatic fever; a persistent dilemma. Pediatrics. 2000;105:1375.
Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. JAMA. 1992;268(15):2069–73
Beg A, Sadiq M. Subclinical valvulitis in children with acute rheumatic fever. Pediatr Cardiol. 2008;29:619–23.
Ferrieri P, for the Jones Criteria Working Group. Proceedings of the Jones criteria workshop. Circulation. 2002;106:2521–3.
Guilherme L, Ramasawmy R, Kalil J. Rheumatic fever and rheumatic heart disease: genetics and pathogenesis. Scand J Immunol. 2007;66:199–207.
Olmez U, Turgay M, Ozenirler S, et al. Association of HLA class I and class II antigens with rheumatic fever in a Turkish population. Scand J Rheumatol. 1993;22:49–52.
Khanna AK, Gibofsky A, et al. Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibody. J Clin Invest. 1989;8:1710–6.
Harel L, Zeharia A, Kodman Y, Straussberg R, Zabriskie JB, Amir J. Presence of the d8/17 B-cell marker in children with rheumatic fever in Israel. Clin Genet. 2002;61:293–8.
Kaplan MH, Meyeserian M. An immunological cross-reaction between group-A streptococcal cells and human heart tissue. Lancet. 1962;279:706–10.
Kaplan MH, Frengley JD. Autoimmunity to the heart in cardiac disease. Current concepts of the relation of autoimmunity to rheumatic fever, postcardiotomy and postinfarction syndromes and cardiomyopathies. Am J Cardiol. 1969;24:459–73.
Singer HS, Loiselle CR, Lee O, Garvey MA, Grus FH. Anti-basal ganglia antibody abnormalities in Sydenham chorea. J Neuroimmunol. 2003;136:154–61.
Kirvan CA, Swedo SE, Heuser JS, Cunningham MW. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med. 2003;9:914–20.
Heye N, Jergas M, Hötzinger H, Farahati J, Pöhlau D, Przuntek H. Sydenham chorea: clinical, EEG, MRI and SPECT findings in the early stage of the disease. J Neurol. 1993;240:121–3.
Faustino PC, Terreri MT, da Rocha AJ, Zappitelli MC, Lederman HM, Hilário MO. Clinical, laboratory, psychiatric and magnetic resonance findings in patients with Sydenham chorea. Neuroradiology. 2003;45:456–62.
Hashkes PJ, Tauber T, Someh E, et al. Naproxen as an alternative to Aspirin for the treatment of Arthritis of Rheumatic fever: a randomized trial. J Pediatr. 2003;143(3):399–401.
Carapetis JR, Brown A, Wilson NJ, Edwards KN. An Australian guideline for rheumatic fever and rheumatic heart disease: an abridged outline. Med J Aust. 2007;186:581–6.
Barash J, Margalith D, Matitiau A. Corticosteroid treatment in patients with Sydenham’s chorea. Pediatr Neurol. 2005;32(3):205–7.
Paz JA, Silva CA, Marques-Dias MJ. Randomized double-blind study with prednisone in Sydenham’s chorea. Pediatr Neurol. 2006;34:264–9.
Daoud AS, Zaki M, Shakir R, al-Saleh Q. Effectiveness of sodium valproate in the treatment of Sydenham’s chorea. Neurology. 1990;40970:1140–1.
Harel I, Zecharia A, Straussberg R, et al. Successful treatment of rheumatic chorea with carbamazepine. Pediatr Neurol. 2000;23(2):147–51.
•• Gerber MA, Baltimore RS, Eaton CB, Gewitz M, Rowley AH, Shulman ST, et al. Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation. 2009;119(11):1541–51. A very important paper dealing with most recent recommendations for preventing ARF.
Crea MA, Mortimer Jr EA. The nature of scarlatinal arthritis. Pediatrics. 1959;23(5):879–84.
De Cunto CL, Giannini EH, Fink CW, Brewer EJ, Person DA. Prognosis of children with poststreptococcal reactive arthritis. Pediatr Infect Dis J. 1988;7(10):683–6.
Jansen TL, Janssen M, de Jong AJ, Jeurissen ME. Post-streptococcal reactive arthritis: a clinical and serological description, revealing its distinction from acute rheumatic fever. J Intern Med. 1999;245(3):261–7.
Mackie SL, Keat A. Poststreptococcal reactive arthritis: what is it and how do we know? Rheumatology (Oxford). 2004;43(8):949–54.
Simonini G, Taddio A, Cimaz R. No evidence yet to change American Heart Association recommendations for poststreptococcal reactive arthritis: comment on the article by van Bemmel et al. Arthritis Rheum. 2009;60(11):3516–8.
Ayoub EM, Ahmed S. Update on complications of group A streptococcal infections. Curr Probl Pediatr. 1997;27(3):90–101.
•• Barash J, Mashiach E, Navon-Elkan P, Berkun Y, Harel L, Tauber T. et al. Differentiation of post-streptococcal reactive arthritis from acute rheumatic fever. J Pediatr. 2008;153(5):696–9. This paper shows very clearly that ARF and PsRA are two different entities and offers a mathematical formula to differentiate ARF and PsRA.
Moorthy LN, Gaur S, Peterson MG, Landa YF, Tandon M, Lehman TJ. Poststreptococcal reactive arthritis in children: a retrospective study. Clin Pediatr. 2009;48(2):174–82.
Schaffer FM, Agarwal R, Helm J, Gingell RL, Roland JM, O'Neil KM. Poststreptococcal reactive arthritis and silent carditis: a case report and review of the literature. Pediatrics. 1994;93(5):837–9.
van Bemmel JM, Delgado V, Holman ER, Allaart CF, Huizinga TW, Bax JJ, et al. No increased risk of valvular heart disease in adult poststreptococcal reactive arthritis. Arthritis Rheum. 2009;60(4):987–93.
Harel L, Mukamel M, Zeharia A, Kodman Y, Prais D, Uziel Y, et al. Presence of D8/17 B-cell marker in patients with poststreptococcal reactive arthritis. Rheumatol Int. 2007;27(8):695–8.
Kaplan EL, Rothermel CD, Johnson DR. Antistreptolysin O and anti-deoxyribonuclease B titers: normal values for children ages 2 to 12 in the United States. Pediatrics. 1998;101:86–8.
Conflict of Interest
No potential conflicts of interest relevant to this article were reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Barash, J. Rheumatic Fever and Post-Group A Streptococcal Arthritis in Children. Curr Infect Dis Rep 15, 263–268 (2013). https://doi.org/10.1007/s11908-013-0335-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11908-013-0335-3